| Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ... European Journal of Pharmaceutical Sciences 137, 104967, 2019 | 403 | 2019 |
| Dual chitosan/albumin-coated alginate/dextran sulfate nanoparticles for enhanced oral delivery of insulin M Lopes, N Shrestha, A Correia, MA Shahbazi, B Sarmento, J Hirvonen, ... Journal of controlled release 232, 29-41, 2016 | 215 | 2016 |
| Overcoming the intestinal barrier: a look into targeting approaches for improved oral drug delivery systems Y Xu, N Shrestha, V Preat, A Beloqui Journal of Controlled Release 322, 486-508, 2020 | 202 | 2020 |
| An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers Y Xu, N Shrestha, V Préat, A Beloqui Advanced Drug Delivery Reviews 175, 113795, 2021 | 189 | 2021 |
| The impact of nanoparticles on the mucosal translocation and transport of GLP-1 across the intestinal epithelium F Araújo, N Shrestha, MA Shahbazi, P Fonte, EM Mäkilä, JJ Salonen, ... Biomaterials 35 (33), 9199-9207, 2014 | 183 | 2014 |
| Microfluidic assembly of a multifunctional tailorable composite system designed for site specific combined oral delivery of peptide drugs F Araujo, N Shrestha, MA Shahbazi, D Liu, B Herranz-Blanco, EM Makila, ... ACS nano 9 (8), 8291-8302, 2015 | 132 | 2015 |
| Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers N Shrestha, MA Shahbazi, F Araújo, H Zhang, EM Mäkilä, J Kauppila, ... Biomaterials 35 (25), 7172-7179, 2014 | 128 | 2014 |
| Thiolation and cell‐penetrating peptide surface functionalization of porous silicon nanoparticles for oral delivery of insulin N Shrestha, F Araújo, MA Shahbazi, E Mäkilä, MJ Gomes, ... Advanced Functional Materials 26 (20), 3405-3416, 2016 | 117 | 2016 |
| Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: a controlled dual protein-drug delivery system N Shrestha, MA Shahbazi, F Araujo, E Mäkilä, J Raula, EI Kauppinen, ... Biomaterials 68, 9-20, 2015 | 104 | 2015 |
| PEG-PGA enveloped octaarginine-peptide nanocomplexes: an oral peptide delivery strategy Z Niu, E Samaridou, E Jaumain, J Coëne, G Ullio, N Shrestha, J Garcia, ... Journal of controlled release 276, 125-139, 2018 | 96 | 2018 |
| Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release B Herranz-Blanco, LR Arriaga, E Mäkilä, A Correia, N Shrestha, S Mirza, ... Lab on a Chip 14 (6), 1083-1086, 2014 | 92 | 2014 |
| Multifunctional self-assembled peptide hydrogels for biomedical applications M Sedighi, N Shrestha, Z Mahmoudi, Z Khademi, A Ghasempour, ... Polymers 15 (5), 1160, 2023 | 86 | 2023 |
| In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy F Araujo, N Shrestha, MJ Gomes, B Herranz-Blanco, D Liu, JJ Hirvonen, ... Nanoscale 8 (20), 10706-10713, 2016 | 85 | 2016 |
| Oral hypoglycaemic effect of GLP-1 and DPP4 inhibitor based nanocomposites in a diabetic animal model N Shrestha, F Araujo, MA Shahbazi, E Mäkilä, MJ Gomes, M Airavaara, ... Journal of Controlled Release 232, 113-119, 2016 | 71 | 2016 |
| Safety and toxicity concerns of orally delivered nanoparticles as drug carriers F Araújo, N Shrestha, PL Granja, J Hirvonen, HA Santos, B Sarmento Expert opinion on drug metabolism & toxicology 11 (3), 381-393, 2015 | 71 | 2015 |
| A prospective cancer chemo-immunotherapy approach mediated by synergistic CD326 targeted porous silicon nanovectors MA Shahbazi, N Shrestha, E Mäkilä, F Araújo, A Correia, T Ramos, ... Nano Research 8 (5), 1505-1521, 2015 | 64 | 2015 |
| Spray drying of fenofibrate loaded nanostructured lipid carriers D Xia, N Shrestha, J van de Streek, H Mu, M Yang asian journal of pharmaceutical sciences 11 (4), 507-515, 2016 | 56 | 2016 |
| The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers N Shrestha, O Bouttefeux, K Vanvarenberg, P Lundquist, J Cunarro, ... Nanoscale, 2018 | 53 | 2018 |
| Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease N Shrestha, Y Xu, JRC Prévost, F McCartney, D Brayden, R Frédérick, ... Acta biomaterialia 140, 561-572, 2022 | 50 | 2022 |
| Intracellular responsive dual delivery by endosomolytic polyplexes carrying DNA anchored porous silicon nanoparticles MA Shahbazi, PV Almeida, A Correia, B Herranz-Blanco, N Shrestha, ... Journal of Controlled Release 249, 111-122, 2017 | 45 | 2017 |
Hélder A. SantosUniversity Medical Center Groningen/University of GroningenVerified email at umcg.nl
